Speaker Profile
M.D., Director, PHASER Precision Medicine Program, National Oncology Program Office, VA Healthcare
Biography
Deepak Voora, MD, is Associate Professor of Medicine at Duke University School of Medicine, a staff cardiologist at the Durham Veterans Affairs Medical Center, and Executive Director for the VA's National Pharmacogenomics Program. His research focusses on the discovery and translation of pharmacogenomic biomarkers to improve health outcomes for some of the most commonly used medications used worldwide. As Director of the VA's National Pharmacogenomics Program, he is leading the VAs clinical implementation of panel-based, pharmacogenomic testing enterprise-wide.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Kristine Ashcraft, YouScript
Program Theme: Addressing Persistent PGx Myths
- PMWC 2025 Award Ceremony:
Luminary Honoree: Philip E. Empey, UPMC
Pioneer Honoree: Collen Masimirembwa, University of the Witwatersrand
- Keynote: Genomic Diversity in Africa: Pharmacogenetics and Clinical Applications
- Collen Masimirembwa, University of the Witwatersrand
- PGx is Expensive and Insurance Coverage is Limited (PANEL)
Chair: Jai Patel, Atrium Health
- Lena Chaihorskym, Alva10
- Mark Fleury, ACS CAN
- Kristine Ashcraft, YouScript
- Alison L. Quinn, Kaiser - Science Backing PGx is Limited (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Russ Altman, Stanford
- Philip E. Empey, UPMC
- Jeff Shaman, Coriell Life Sciences
- PGx is Hard to Implement (PANEL)
Chair: Kristine Crews, St Jude
- Suzanne Stevens, Wentworth-Douglass Hospital
- Deepak Voora, VA
- Jennifer Wick, The Christ Hospital Health Network
- Latha Palaniappan, Stanford - Fireside Chat
Chair: Damon Hostin, Illumina
- Dan Hertz, University of Michigan - What will It Take to Make PGx the Standard of Care? (PANEL)
Chair: Kristine Ashcraft, YouScript
- Alan Venook, UCSF/ NCCN
- Gary Marchant, ASU
- Dan Hertz, University of Michigan
- Deepak Voora, VA
